Close Menu
Home » SpeeDx Raises Additional $15M

SpeeDx Raises Additional $15M

Feb 11, 2020
|
staff reporter

NEW YORK — Australian diagnostics firm SpeeDx said on Tuesday that it has raised $15 million in new Series B funding.

The investment was made by Northpond Ventures, which last year invested $20 million in SpeeDx. 

The firm will use the additional funds to support its product and services pipeline, SpeeDx CFO Bhavin Raval said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Test of Antibodies

According to NPR, an antibody-based test could identify people who were exposed to SARS-CoV-2 and either didn't develop symptoms or were misdiagnosed.

New York Rats Through and Through

A sequencing analysis of New York City rats indicates they have adapted to the urban environment there, according to a recent preprint.

Powerhouse of the Cell, Lost

Ars Technica reports that a multicellular eukaryotic parasite has lost its mitochondria.

Science Papers Discuss AI in Drug Discovery, Find Two Red Panda Species

In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.

Mar
18
Featured Webinar

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar
31
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Molecular Diagnostics

  1. CDC Revises SARS-CoV-2 Assay Protocol; Surveillance Testing on Track to Start Next Week

  2. Cepheid, Sherlock Biosciences Partner on SARS-CoV-2 Diagnostic Test

  3. Congressional Caucus Working to Raise Personalized Medicine Awareness Among Legislators

    Premium

  4. PerkinElmer SCID Test Chosen for Newborn Screening Evaluation in England

  5. Guardant Health to Focus on Early Cancer Detection and Monitoring, CDx Development in 2020

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.